发明名称 PROTEOGLYCAN DEGRADING MUTANT FOR TREATMENT OF CNS
摘要 PROBLEM TO BE SOLVED: To provide mutants of chondroitinase genes, polypeptides and proteins derived therefrom, and methods for promoting neurological functional recovery after a central nervous system injury or disease.SOLUTION: A method for treating a central nervous system injury or disease by a fusion protein comprising a purified chondroitinase AC mutant polypeptide binding to a component selected from soluble NOGO antagonists, neural cell adhesion factors, neurotrophic factors, growth factors, phosphodiesterase inhibitors, inhibitors of MAG or MOG, neuregulins and antibodies that promote remyelination.
申请公布号 JP2013223500(A) 申请公布日期 2013.10.31
申请号 JP20130122076 申请日期 2013.06.10
申请人 ACORDA THERAPEUTICS INC 发明人 GRUSKIN ELLIOTT A;CAGGIANO ANTHONY O;ROY GARGI;D'SOUZA ROHINI
分类号 C12N9/24;A61K;A61K31/00;A61K38/00;A61K45/00;A61P9/00;A61P25/00;A61P27/02;C07K19/00;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N15/09 主分类号 C12N9/24
代理机构 代理人
主权项
地址